Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1288.25%
operating margin TTM
-770.2%
revenue TTM
9.02 Million
revenue per share TTM
1.31$
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | 0.00 |
| price to book ratio | 0.00 |
| price to sales ratio | 10.70 |
| enterprise value multiple | -2.71 |
| price fair value | 0.00 |
profitability ratios | |
|---|---|
| gross profit margin | 23.07% |
| operating profit margin | -770.2% |
| pretax profit margin | -1287.82% |
| net profit margin | -1288.25% |
| return on assets | -79.83% |
| return on equity | -142.89% |
| return on capital employed | -53.77% |
liquidity ratio | |
|---|---|
| current ratio | 6.50 |
| quick ratio | 6.04 |
| cash ratio | 5.40 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 395.22 |
| operating cycle | 687.54 |
| days of payables outstanding | 213.69 |
| cash conversion cycle | 473.85 |
| receivables turnover | 1.25 |
| payables turnover | 1.71 |
| inventory turnover | 0.92 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.04 |
| long term debt to capitalization | 0.03 |
| total debt to capitalization | 0.04 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -11.41 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2,696.93 |
| cash per share | 4,363.86 |
| operating cash flow per share | -2,671.71 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -11.41 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -511.50 |
Frequently Asked Questions
When was the last time Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) reported earnings?
Tonix Pharmaceuticals Holding Corp. (TNXP) published its most recent earnings results on 12-11-2024.
What is Tonix Pharmaceuticals Holding Corp.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)'s trailing twelve months ROE is -142.89%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Tonix Pharmaceuticals Holding Corp. (TNXP) currently has a ROA of -79.83%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TNXP's net profit margin stand at?
TNXP reported a profit margin of -1288.25% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TNXP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.50 in the most recent quarter. The quick ratio stood at 6.04, with a Debt/Eq ratio of 0.04.